The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
170 jobs Number of planned job creations
Announcement Date
31 March 2008
Employment effect (start)
Foreseen end date
31 March 2011
Description
Genzyme, a US biotechnology company that employs over 400 people, has announced that intends to invest €130 million at its plant in Waterford city. The investment has been supported by the Industrial Development Agency and it will create 170 high-skilled positions in manufacturing, quality and engineering over the next three years.
A spokesman remarked that the expansion of the company’s Waterford campus will see investment in expanding production capacity.
Sources
1 April 2008: The Irish Times
Citation
Eurofound (2008), Genzyme, Business expansion in Ireland, factsheet number 66464, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66464.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
